These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 11455176)

  • 21. Neuropathology of parkinsonism in patients with pure Alzheimer's disease.
    Horvath J; Burkhard PR; Herrmann FR; Bouras C; Kövari E
    J Alzheimers Dis; 2014; 39(1):115-20. PubMed ID: 24121968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular parkinsonism.
    Sibon I; Fenelon G; Quinn NP; Tison F
    J Neurol; 2004 May; 251(5):513-24. PubMed ID: 15164182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portable device for quantifying parkinsonian wrist rigidity.
    Caligiuri MP
    Mov Disord; 1994 Jan; 9(1):57-63. PubMed ID: 7908119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Burns RS; Chiueh CC; Markey SP; Ebert MH; Jacobowitz DM; Kopin IJ
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4546-50. PubMed ID: 6192438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease.
    Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM
    Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism.
    Rampello L; Alvano A; Battaglia G; Raffaele R; Vecchio I; Malaguarnera M
    J Neurol; 2005 Sep; 252(9):1045-9. PubMed ID: 15940389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between cerebral vascular disease and parkinsonism: The VADO study.
    Antonini A; Vitale C; Barone P; Cilia R; Righini A; Bonuccelli U; Abbruzzese G; Ramat S; Petrone A; Quatrale R; Marconi R; Ceravolo R; Stefani A; Lopiano L; Zappia M; Capus L; Morgante L; Tamma F; Tinazzi M; Colosimo C; Guerra UP
    Parkinsonism Relat Disord; 2012 Jul; 18(6):775-80. PubMed ID: 22531611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation.
    Raff U; Hutchinson M; Rojas GM; Huete I
    Acad Radiol; 2006 Jun; 13(6):721-7. PubMed ID: 16679274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel grading scale for striatonigral degeneration (multiple system atrophy).
    Wenning GK; Seppi K; Tison F; Jellinger K
    J Neural Transm (Vienna); 2002 Mar; 109(3):307-20. PubMed ID: 11956953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tremulous jaw movements in rats: a model of parkinsonian tremor.
    Salamone JD; Mayorga AJ; Trevitt JT; Cousins MS; Conlan A; Nawab A
    Prog Neurobiol; 1998 Dec; 56(6):591-611. PubMed ID: 9871939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrapyramidal motor symptoms versus striatal infarction volume after focal ischemia in mongolian gerbils.
    Ishibashi S; Kuroiwa T; Katsumata N; Yuan SL; Endo S; Mizusawa H
    Neuroscience; 2004; 127(2):269-75. PubMed ID: 15262318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcranial sonography in the discrimination of Parkinson's disease versus vascular parkinsonism.
    Venegas-Francke P
    Int Rev Neurobiol; 2010; 90():147-56. PubMed ID: 20692499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.
    Yoshida M; Ogawa M; Suzuki K; Nagatsu T
    Adv Neurol; 1993; 60():207-11. PubMed ID: 8093578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease.
    Pujol J; Junqué C; Vendrell P; Grau JM; Capdevila A
    Arch Neurol; 1992 Nov; 49(11):1119-22. PubMed ID: 1444876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging.
    Adachi M; Hosoya T; Haku T; Yamaguchi K; Kawanami T
    AJNR Am J Neuroradiol; 1999 Sep; 20(8):1500-6. PubMed ID: 10512237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
    Hausner RS
    J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis.
    Pradhan S; Pandey N; Shashank S; Gupta RK; Mathur A
    Neurology; 1999 Nov; 53(8):1781-6. PubMed ID: 10563628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features, diagnosis, and imaging of parkinsonian syndromes.
    Poewe W
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):333-8. PubMed ID: 8507902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.